DE19812688A1 - Verfahren zur Herstellung von festen Dosierungsformen - Google Patents

Verfahren zur Herstellung von festen Dosierungsformen

Info

Publication number
DE19812688A1
DE19812688A1 DE19812688A DE19812688A DE19812688A1 DE 19812688 A1 DE19812688 A1 DE 19812688A1 DE 19812688 A DE19812688 A DE 19812688A DE 19812688 A DE19812688 A DE 19812688A DE 19812688 A1 DE19812688 A1 DE 19812688A1
Authority
DE
Germany
Prior art keywords
acid
dosage forms
erolin
additives
graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19812688A
Other languages
German (de)
English (en)
Inventor
Stephan Kothrade
Gunther Berndl
Dirk Simon
Axel Sanner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to DE19812688A priority Critical patent/DE19812688A1/de
Priority to US09/268,719 priority patent/US7022344B1/en
Priority to EP99105799A priority patent/EP0950404B1/de
Priority to CA002264287A priority patent/CA2264287C/en
Priority to DE59909717T priority patent/DE59909717D1/de
Priority to AT99105799T priority patent/ATE269060T1/de
Priority to JP07868099A priority patent/JP4813634B2/ja
Publication of DE19812688A1 publication Critical patent/DE19812688A1/de
Priority to US11/039,695 priority patent/US7419685B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F279/00Macromolecular compounds obtained by polymerising monomers on to polymers of monomers having two or more carbon-to-carbon double bonds as defined in group C08F36/00
    • C08F279/02Macromolecular compounds obtained by polymerising monomers on to polymers of monomers having two or more carbon-to-carbon double bonds as defined in group C08F36/00 on to polymers of conjugated dienes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L51/00Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
    • C08L51/04Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to rubbers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19812688A 1998-03-23 1998-03-23 Verfahren zur Herstellung von festen Dosierungsformen Withdrawn DE19812688A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE19812688A DE19812688A1 (de) 1998-03-23 1998-03-23 Verfahren zur Herstellung von festen Dosierungsformen
US09/268,719 US7022344B1 (en) 1998-03-23 1999-03-17 Process for producing solid dosage forms
EP99105799A EP0950404B1 (de) 1998-03-23 1999-03-22 Verfahren zur Herstellung von festen Dosierungsformen
CA002264287A CA2264287C (en) 1998-03-23 1999-03-22 A process for producing solid dosage forms
DE59909717T DE59909717D1 (de) 1998-03-23 1999-03-22 Verfahren zur Herstellung von festen Dosierungsformen
AT99105799T ATE269060T1 (de) 1998-03-23 1999-03-22 Verfahren zur herstellung von festen dosierungsformen
JP07868099A JP4813634B2 (ja) 1998-03-23 1999-03-23 固形投与形の製造法、該投与形及び結合剤としてのグラフトコポリマーの使用
US11/039,695 US7419685B2 (en) 1998-03-23 2005-01-21 Process for producing solid dosage forms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19812688A DE19812688A1 (de) 1998-03-23 1998-03-23 Verfahren zur Herstellung von festen Dosierungsformen

Publications (1)

Publication Number Publication Date
DE19812688A1 true DE19812688A1 (de) 1999-09-30

Family

ID=7861972

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19812688A Withdrawn DE19812688A1 (de) 1998-03-23 1998-03-23 Verfahren zur Herstellung von festen Dosierungsformen
DE59909717T Expired - Lifetime DE59909717D1 (de) 1998-03-23 1999-03-22 Verfahren zur Herstellung von festen Dosierungsformen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59909717T Expired - Lifetime DE59909717D1 (de) 1998-03-23 1999-03-22 Verfahren zur Herstellung von festen Dosierungsformen

Country Status (6)

Country Link
US (2) US7022344B1 (enExample)
EP (1) EP0950404B1 (enExample)
JP (1) JP4813634B2 (enExample)
AT (1) ATE269060T1 (enExample)
CA (1) CA2264287C (enExample)
DE (2) DE19812688A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998920A1 (de) * 1998-10-15 2000-05-10 Basf Aktiengesellschaft Verfahren zur Herstellung von festen Dosierungsformen
WO2006125450A1 (en) * 2005-05-26 2006-11-30 Atef Mohammed Mostafa Darwish Rectal and vaginal suppositories containing misoprostol

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814739A1 (de) * 1998-04-02 1999-10-07 Basf Ag Verwendung von Polyalkylenoxid-haltigen Pfropfpolymerisaten als Solubilisatoren
CA2391707C (en) * 1999-07-30 2010-05-11 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
GB0102342D0 (en) 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AU2004232370B2 (en) * 2003-04-21 2009-12-10 Euro-Celtique S.A. Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CA2548834C (en) * 2003-12-09 2009-08-11 Euro-Celtique S.A. Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
JP4907514B2 (ja) * 2005-01-28 2012-03-28 株式会社リバース・プロテオミクス研究所 効率的にターゲット分子を探索する方法
EP1920767A1 (en) * 2006-11-09 2008-05-14 Abbott GmbH & Co. KG Melt-processed imatinib dosage form
EP2219624A2 (en) 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
RU2013118252A (ru) 2010-09-22 2014-10-27 МакНЕЙЛ-ППС, ИНК. Производство таблеток из порошковой смеси, обработанной излучением
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1043039A (en) * 1973-01-29 1978-11-21 Robert D. Lundberg Multiphase block and graft copolymers comprising a hydrophilic continuous phase and hydrophobic domains
FR2433949A1 (fr) * 1978-08-25 1980-03-21 Commissariat Energie Atomique Substrat hydrophobe apte a liberer une substance chimique
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3812567A1 (de) 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
DE3830353A1 (de) 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
FR2699406B1 (fr) * 1992-12-21 1995-03-10 Commissariat Energie Atomique Films à base de copolymères, leurs applications dans des systèmes transdermiques et leurs procédés de préparation.
KR970701739A (ko) 1994-03-04 1997-04-12 브라운 데이비드 피. 블록 공중합체와 그라프트 공중합체 및 이들과 연관된 방법(Block and graft copolymers and methods relating thereto)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998920A1 (de) * 1998-10-15 2000-05-10 Basf Aktiengesellschaft Verfahren zur Herstellung von festen Dosierungsformen
WO2006125450A1 (en) * 2005-05-26 2006-11-30 Atef Mohammed Mostafa Darwish Rectal and vaginal suppositories containing misoprostol

Also Published As

Publication number Publication date
ATE269060T1 (de) 2004-07-15
JP4813634B2 (ja) 2011-11-09
US20050129757A1 (en) 2005-06-16
CA2264287C (en) 2008-10-07
DE59909717D1 (de) 2004-07-22
EP0950404A3 (de) 1999-12-29
US7022344B1 (en) 2006-04-04
JPH11322585A (ja) 1999-11-24
CA2264287A1 (en) 1999-09-23
US7419685B2 (en) 2008-09-02
EP0950404B1 (de) 2004-06-16
EP0950404A2 (de) 1999-10-20

Similar Documents

Publication Publication Date Title
EP1035841B1 (de) Verfahren zur herstellung von festen dosierungsformen
EP0998918B1 (de) Feste Dosierungsform mit copolymerem Bindemittel
EP0864326B1 (de) Mehrphasige wirkstoffhaltige Zubereitungsformen
EP0930875B1 (de) Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung
EP0998920B1 (de) Verfahren zur Herstellung von festen Dosierungsformen
EP0950404B1 (de) Verfahren zur Herstellung von festen Dosierungsformen
EP1158962B1 (de) Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen
DE19856147A1 (de) Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung
DE19710213A1 (de) Verfahren zur Herstellung von festen Kombinationsarzneiformen
DE19839276A1 (de) Verfahren zur Herstellung von festen Dosierungsformen
DE19753300A1 (de) Verfahren zur Herstellung von festen Dosierungsformen
EP1556012A2 (de) Herstellung von festen dosierungsformen unter verwendung eines vernetzten nicht-thermoplastischen tr gers
DE19800927A1 (de) Verfahren zur Herstellung von festen Dosierungsformen
DE19753299A1 (de) Verfahren zur Herstellung von festen Dosierungsformen
WO2008080773A1 (de) Verfahren zur herstellung von festen dosierungsformen enthaltend pfropfcopolymere
EP0998919A2 (de) Feste Dosierungsform mit copolymerem Bindemittel
WO1997015291A1 (de) Verfahren zur herstellung von festen arzneiformen
DE19753297A1 (de) Verfahren zur Herstellung von festen Dosierungsformen
DE19637479A1 (de) Verfahren zur Herstellung fester pharmazeutischer Formen
DE19734011A1 (de) Verfahren zur Herstellung fester pharmazeutischer Formen
WO1997015292A1 (de) Verfahren zur herstellung von festen arzneiformen

Legal Events

Date Code Title Description
8130 Withdrawal